1.
William Johnson, Anjali Mishra, Adam Binder, Alejandro Gru, Pierluigi Porcu. Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?. Haematologica 2019;104(5):864-867; https://doi.org/10.3324/haematol.2018.214536.